DM
ALPN

Deerfield Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Deerfield Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-248,992
Closed -$956K – 102
2019
Q4 		$956K Sell
248,992
-157,934
-39% -$492K 0.03% 73
2019
Q3 		$1.61M Sell
406,926
-8,982
-2% -$38.5K 0.07% 88
2019
Q2 		$1.75M Sell
415,908
-59,542
-13% -$344K 0.06% 92
2019
Q1 		$3.26M Hold
475,450
– – 0.13% 81
2018
Q4 		$1.75M Sell
475,450
-137,417
-22% -$678K 0.07% 92
2018
Q3 		$3.88M Sell
612,867
-300,233
-33% -$2.1M 0.14% 91
2018
Q2 		$6.91M Hold
913,100
– – 0.24% 88
2018
Q1 		$7.3M Hold
913,100
– – 0.25% 92
2017
Q4 		$10.2M Sell
913,100
-20,000
-2% -$218K 0.4% 68
2017
Q3 		$10.8M Sell
933,100
-3
-0% -$28 0.49% 60
2017
Q2 		$8.99M Hold
933,103
– – 0.48% 61
2017
Q1 		$10.9M Hold
933,103
– – 0.42% 62
2016
Q4 		$8.36M Hold
933,103
– – 0.34% 63
2016
Q3 		$30.3M Hold
933,103
– – 1.41% 23
2016
Q2 		$17.2M Hold
933,103
– – 0.67% 49
2016
Q1 		$15.6M Hold
933,103
– – 0.66% 47
2015
Q4 		$28.9M Hold
933,103
– – 1.17% 32
2015
Q3 		$48.4M Hold
933,103
– – 1.87% 11
2015
Q2 		$56.5M Buy
+933,103
New +$55.6M 1.88% 11

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management's ALPN Position: Q1 2020 in Review

Deerfield Management sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2020, closing a stake of 248,992 shares — an estimated $956K sold.

Deerfield Management first reported a position in ALPN in Q2 2015 and held it in 19 quarters. The position peaked at $56.5M in Q2 2015. 17 funds tracked by Wall St. Rank hold ALPN as of Q1 2020.

  • Deerfield Management reported no remaining Alpine Immune Sciences Inc position as of Q1 2020 after selling out during the quarter.
  • Deerfield Management sold 248,992 Alpine Immune Sciences Inc shares in Q1 2020, an estimated $956K.
  • Deerfield Management first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 19 quarters.
  • Deerfield Management's Alpine Immune Sciences Inc position peaked at $56.5M in Q2 2015.
  • 17 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2020.

Based on Deerfield Management's 13F filing for Q1 2020, filed 15 May 2020.